Cargando…
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
OBJECTIVE: This study aimed to explore the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration (PKAN). METHODS: A single-arm, open-label study was conducted. All subjects received pantethine during the 24-week period of treatment. The primary endpoints...
Autores principales: | Chang, Xuting, Zhang, Jie, Jiang, Yuwu, Yao, Bufan, Wang, Jingmin, Wu, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491170/ https://www.ncbi.nlm.nih.gov/pubmed/32928263 http://dx.doi.org/10.1186/s13023-020-01530-5 |
Ejemplares similares
-
Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
por: Chang, Xuting, et al.
Publicado: (2020) -
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model
por: Brunetti, Dario, et al.
Publicado: (2014) -
Pantothenate kinase-associated neurodegeneration
por: Hundallah, Khalid, et al.
Publicado: (2017) -
Redesigning therapies for pantothenate kinase–associated neurodegeneration
por: Munshi, Muhammad I., et al.
Publicado: (2022) -
A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
por: Rohani, Mohammad, et al.
Publicado: (2018)